|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
OLC1830494376 |
| 003 |
DE-627 |
| 005 |
20230515075517.0 |
| 007 |
tu |
| 008 |
091125s2009 xx ||||| 00| ||und c |
| 028 |
5 |
2 |
|a sw091125
|
| 035 |
|
|
|a (DE-627)OLC1830494376
|
| 035 |
|
|
|a (DE-599)GBVOLC1830494376
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 082 |
0 |
4 |
|a 610
|
| 084 |
|
|
|a WA 15000
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.48
|2 bkl
|
| 084 |
|
|
|a 44.00
|2 bkl
|
| 100 |
1 |
|
|a Marlin, S.
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Phenotype and genotype in females with POU3F4 mutations
|
| 264 |
|
1 |
|c 2009
|
| 300 |
|
|
|a 6
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Moizard, Mp
|4 oth
|
| 700 |
1 |
|
|a David, A.
|4 oth
|
| 700 |
1 |
|
|a Chaissang, N.
|4 oth
|
| 700 |
1 |
|
|a Raynaud, M.
|4 oth
|
| 700 |
1 |
|
|a Jonard, L.
|4 oth
|
| 700 |
1 |
|
|a Feldmann, D.
|4 oth
|
| 700 |
1 |
|
|a Loundon, N.
|4 oth
|
| 700 |
1 |
|
|a Denoyelle, F.
|4 oth
|
| 700 |
1 |
|
|a Toutain, A.
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical genetics
|d Oxford : Wiley-Blackwell, 1970
|g 76(2009), 6, Seite 558-563
|w (DE-627)129558680
|w (DE-600)221209-2
|w (DE-576)015017486
|x 0009-9163
|7 nnns
|
| 773 |
1 |
8 |
|g volume:76
|g year:2009
|g number:6
|g pages:558-563
|g extent:6
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a GBV_ILN_21
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_105
|
| 912 |
|
|
|a GBV_ILN_2004
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_4012
|
| 912 |
|
|
|a GBV_ILN_4082
|
| 912 |
|
|
|a GBV_ILN_4112
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 936 |
r |
v |
|a WA 15000
|
| 936 |
b |
k |
|a 44.48
|q AVZ
|
| 936 |
b |
k |
|a 44.00
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 76
|j 2009
|e 6
|h 558-563
|g 6
|
